Home > M&A deals 2012 > Ampersand Capital Partners acquires Calloway Laboratories, Inc
Buyout (LBO, MBO, MBI) · Life Science · September 2012

Ampersand Capital Partners acquires Calloway Laboratories, Inc

On September 24, 2012, Ampersand Capital Partners acquired Calloway Laboratories, Inc, a life science company in Massachusetts, United States.

Deal at a glance

AnnouncedSeptember 24, 2012 TypeBuyout (LBO, MBO, MBI) TargetCalloway Laboratories, Inc Buyer Ampersand Capital Partners SectorLife Science LocationMassachusetts, United States ValueNot disclosed

Target company

Calloway Laboratories, Inc
Massachusetts, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Ampersand Capital Partners
Private equity firm · 76 deals on record
  • 9th transaction in life science
  • 32nd transaction in United States
76deals, all time
32in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Syft Technologies Ltd.Same lead buyer · Apr 2022
BioEcho Life Sciences GmbHSame lead buyer · Mar 2022
Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Calloway Laboratories, Inc?Ampersand Capital Partners acquired Calloway Laboratories, Inc on September 24, 2012.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 2012.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).